100 related articles for article (PubMed ID: 15316105)
1. Sincalide in patients with parenteral nutrition-associated gallbladder disease.
Prescott WA; Btaiche IF
Ann Pharmacother; 2004 Nov; 38(11):1942-5. PubMed ID: 15316105
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin prophylaxis of parenteral nutrition-induced gallbladder disease.
Doty JE; Pitt HA; Porter-Fink V; Denbesten L
Ann Surg; 1985 Jan; 201(1):76-80. PubMed ID: 3917658
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans.
Sitzmann JV; Pitt HA; Steinborn PA; Pasha ZR; Sanders RC
Surg Gynecol Obstet; 1990 Jan; 170(1):25-31. PubMed ID: 2104681
[TBL] [Abstract][Full Text] [Related]
4. Ursodiol in patients with parenteral nutrition-associated cholestasis.
San Luis VA; Btaiche IF
Ann Pharmacother; 2007 Nov; 41(11):1867-72. PubMed ID: 17911205
[TBL] [Abstract][Full Text] [Related]
5. Does total parenteral nutrition induce gallbladder sludge formation and lithiasis?
Messing B; Bories C; Kunstlinger F; Bernier JJ
Gastroenterology; 1983 May; 84(5 Pt 1):1012-9. PubMed ID: 6403401
[TBL] [Abstract][Full Text] [Related]
6. Gallbladder disease in patients on long-term parenteral nutrition.
Roslyn JJ; Pitt HA; Mann LL; Ament ME; DenBesten L
Gastroenterology; 1983 Jan; 84(1):148-54. PubMed ID: 6401182
[TBL] [Abstract][Full Text] [Related]
7. Long-term parenteral nutrition in children: liver and gallbladder disease.
Colomb V; Goulet O; Rambaud C; De Potter S; Sadoun E; Ben Hariz M; Jan D; Brousse N; Ricour C
Transplant Proc; 1992 Jun; 24(3):1054-5. PubMed ID: 1604512
[No Abstract] [Full Text] [Related]
8. Intestinal failure-associated liver disease: what do we know today?
Kelly DA
Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
[TBL] [Abstract][Full Text] [Related]
9. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
[TBL] [Abstract][Full Text] [Related]
10. Use of cholecystokinin-octapeptide for the prevention of parenteral nutrition-associated cholestasis.
Teitelbaum DH; Tracy TF; Aouthmany MM; Llanos A; Brown MB; Yu S; Brown MR; Shulman RJ; Hirschl RB; Derusso PA; Cox J; Dahlgren J; Groner JI; Strouse PJ
Pediatrics; 2005 May; 115(5):1332-40. PubMed ID: 15867044
[TBL] [Abstract][Full Text] [Related]
11. Parenteral nutrition associated liver disease.
Kaufman SS; Gondolesi GE; Fishbein TM
Semin Neonatol; 2003 Oct; 8(5):375-81. PubMed ID: 15001125
[TBL] [Abstract][Full Text] [Related]
12. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid.
Cheung HM; Lam HS; Tam YH; Lee KH; Ng PC
Clin Nutr; 2009 Apr; 28(2):209-12. PubMed ID: 19261360
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of disease: update on the molecular etiology and fundamentals of parenteral nutrition associated cholestasis.
Carter BA; Shulman RJ
Nat Clin Pract Gastroenterol Hepatol; 2007 May; 4(5):277-87. PubMed ID: 17476210
[TBL] [Abstract][Full Text] [Related]
14. Treatment of parenteral nutrition-associated cholestasis with cholecystokinin-octapeptide.
Teitelbaum DH; Han-Markey T; Schumacher RE
J Pediatr Surg; 1995 Jul; 30(7):1082-5. PubMed ID: 7472937
[TBL] [Abstract][Full Text] [Related]
15. Gallbladder stasis: consequence of long-term parenteral hyperalimentation and risk factor for cholelithiasis.
Holzbach RT
Gastroenterology; 1983 May; 84(5 Pt 1):1055-8. PubMed ID: 6403402
[No Abstract] [Full Text] [Related]
16. Failure of cholecystokinin-octapeptide to prevent TPN-associated gallstone disease.
Tsai S; Strouse PJ; Drongowski RA; Islam S; Teitelbaum DH
J Pediatr Surg; 2005 Jan; 40(1):263-7. PubMed ID: 15868595
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
18. [Cholestasis associated with prolonged parenteral nutrition in neonates: the role of urso-deoxycholic acid].
Garzón L; Ledo A; Cubells E; Sáenz P; Vento M
An Pediatr (Barc); 2009 Jun; 70(6):547-52. PubMed ID: 19443280
[TBL] [Abstract][Full Text] [Related]
19. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition.
Hermans D; Talbotec C; Lacaille F; Goulet O; Ricour C; Colomb V
J Pediatr Gastroenterol Nutr; 2007 Apr; 44(4):459-63. PubMed ID: 17414144
[TBL] [Abstract][Full Text] [Related]
20. The role of enteral nutrition in the reversal of parenteral nutrition-associated liver dysfunction in infants.
Javid PJ; Collier S; Richardson D; Iglesias J; Gura K; Lo C; Kim HB; Duggan CP; Jaksic T
J Pediatr Surg; 2005 Jun; 40(6):1015-8. PubMed ID: 15991188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
